We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/9/2020 13:05 | Possibly but at this stage they could have missed the boat. | nmulm | |
24/9/2020 13:03 | Looks like this could go back under a quid | volsung | |
24/9/2020 13:01 | I added a few at 1.62 (and a few earlier in the week at 1.73p). The drop doesn't overly concern me despite the drop in the value currently of my holding. The reason I'm sanguine about it is that the market cap of £250m seems about right given where we are and the uncertainty over next steps. However unless they have really over played the headline results, we know this works, which is backed up by numerous independent papers. Once the paper is finally published, assuming it doesn't over turn the headline results, we'll see this pop back up rapidly. Further, it's likely it will be published in the next days/weeks it looks like that will be in the midst of the current wave and general govt panic (2nd budget in a row to be cancelled) the clamour to get it approved and used in settings such as care homes, will be huge, especially when the numbers hopefully confirm (but need home trial results to confirm IMO) that given early it keeps XX% out of ever needing hospital treatment. | waterloo01 | |
24/9/2020 12:31 | ‘Visible’ Presumably those selling sub 170p are selling at a loss? | wetdream |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions